Journal of Hebei Medical University

Previous Articles     Next Articles

Impact of 20 mg atorvastatin calcium on hsCRP and MMP9 of asymptomatic carotid plaque patients

  

  1. 1.Department of  Neurology, the First Hospital of Hebei Medical University, Shijiazhuang 050031, China;
    2.Department of Ultrasound, the First Hospital of Hebei Medical University, Shijiazhuang 050031, China;
    3.Department of Pharmaceutical Engineering,Shijiazhuang Vocational College of
    Science and Technology, Shijiazhuang 052165, China
  • Online:2016-07-25 Published:2016-08-11

Abstract: [
Abstract ] Objective Toobservethelong-termeffectoflowdoseatorvastatinontheserum
high-sensitivityC-reactiveprotein ( hsCRP ) and matrix metalloproteinase-9 ( MMP-9 ) among
neurologicallyasymptomaticpatients withultrasounddefinedunstablecarotidatherosclerotic
plaque.Methods Atotalof73caseswererandomlydividedintotreatmentgroup ( n =38 ) and
controlgroup ( n =35 ) .Thetreatmentgroupreceivedaspirin100mgplusatorvastatin20mgper
day , whereasthecontrolgrouponlytookaspirin100mgperday.ThelevelsofserumhsCRP
,
MMP-9 , totalcholesterol ( TC ), weremeasuredbeforeandaftertreatmentin6and12months.
Andtheendeventsandadversereactionsofthe2groupswererecorded.Results Therewasno
differenceinthelevelsofserum TC , lowdensitylipoproteincholesterol ( LDL-C ), hsCRPand
MMP-9incontrolgroup.Intreatmentgroup , thelevelsofserumTC , LDL-C , hsCRPandMMP-
9atthe6monthsand12monthsoffollow-upwerelowerthanthatbeforetreatment ( P <0.05 )  Conclusion Low-doseatorvastatinnotonlycouldregulateTC , butalsoreducethelevelsof
seruminflammatory mediators MMP-9andhsCRP , inhibitinflammatoryreactionandstable
plaque , therebypreventingtheoccurrenceofischemiccerebrovasculardisease.

Key words: plaque, atherosclerotic; atorvastatin calcium, Creactive protein